The product liability lawyers at Saiontz & Kirk, P.A. are evaluating whether compensation may be available through an Effient lawsuit for individuals diagnosed with new cancers or worsening solid tumors after using the relatively new blood thinner. Experts have expressed concern that Effient side effects may increase the relative risk of certain cancers.

According to an analysis published in the Archives of Internal Medicine in June 2010, Effient may promote tumor growth when compared to the competing blood thinner Plavix. Researchers looked at data from a clinical trial that was used to gain FDA approval for the blood thinner, known as TRITON-TIMI 38.

It appears that Eli Lilly & Co., the manufacturer of Effient, may have failed to adequately evaluate the risk of cancer from Effient or warn about the potential side effects.

The Effient lawyers at Saiontz & Kirk, P.A. are evaluating the potential for lawsuits over cancer from Effient. To submit information about a potential case for review by our attorneys, request a free consultation and claim evaluation. All cases are being reviewed on a contingency fee basis, which means that there are no fees or expenses unless a recovery is obtained.